BRCA1 and endometrial cancer: Among carriers of germline mutations in BRCA1/2 genes, the absolute risk of developing endometrial cancer up to 75 years of age is 3% (similar to life risk in the general population—2.9% [76] (strength of evidence V)), and for the serous type, 1.1% [93] (strength of evidence IIIA).